Skip to main content
Year archive

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD — 2019 filings

All 42 regulatory filings released by NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD (NSB) in 2019, sourced directly from the official regulator.

42 Filings
2019 Period
2019 filings (42)
Filing Released Lang
NSB - Glaucoma Study Update 1 page 148.9KB
Regulatory Filings
2019-12-23 English
Appendix 4G 11 pages 194.0KB
Regulatory Filings
2019-12-16 English
Appendix 3B 11 pages 373.6KB
Capital/Financing Update
2019-12-16 English
CVN Model Indicates Neuroprotective Properties of EmtinB 5 pages 399.4KB
Regulatory Filings
2019-12-05 English
NSB - Company Update 1 page 172.2KB
Regulatory Filings
2019-12-01 English
AGM Address 17 pages 1.6MB
AGM Information
2019-11-28 English
Results of AGM 2 pages 240.7KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-28 English
NSB Presentation Nov 2019 22 pages 2.6MB
Investor Presentation
2019-11-18 English
NSB - Company Update 3 pages 230.4KB
Capital/Financing Update
2019-11-17 English
Appendix 3B - Options Exercised 11 pages 371.4KB
Capital/Financing Update
2019-10-31 English
Notice of Annual General Meeting/Proxy Form 28 pages 987.8KB
AGM Information
2019-10-28 English
Appendix 4C - quarterly 5 pages 160.9KB
Interim / Quarterly Report Q1 2019
2019-10-27 English
NSB Correction to Presentation 21 pages 1.6MB
Investor Presentation
2019-10-23 English
NSB - Techknow Conference Presentation Oct 19 20 pages 973.0KB
Investor Presentation
2019-10-21 English
Appendix 3B - Options Exercised 11 pages 369.0KB
Share Issue/Capital Change
2019-10-02 English
EmtinB Can Become a Revolutionary Treatment for Glaucoma 3 pages 401.6KB
Regulatory Filings
2019-09-30 English
Trading Halt 2 pages 246.4KB
Regulatory Filings
2019-09-26 English
NSB Receives R&D Advanced Overseas Finding 1 page 1
Regulatory Filings
2019-09-01 English
Appendix 4E and Annual Report 46 pages 837.6KB
Annual Report FY 2019
2019-08-29 English
NSB Invited to Present at Bio Investor Forum - San Francisco 1
Investor Presentation
2019-08-13 English
Appendix 3B - Options Exercised 11 pages 370.5KB
Capital/Financing Update
2019-08-08 English
NSB - FInal Data Received from Spinal Cord Injury Model 3 pages 337.7KB
Regulatory Filings
2019-07-30 English
Trading Halt 2 pages 347.5KB
Regulatory Filings
2019-07-29 English
Appendix 4C - quarterly 5 pages 161.6KB
Interim / Quarterly Report Q4 2019
2019-07-29 English
Appendix 3B - Escrow Release 14 pages 459.0KB
Share Issue/Capital Change
2019-07-24 English
Appendix 3B - Options Exercised 11 pages 370.1KB
Capital/Financing Update
2019-07-18 English
Notice under ASX Listing rule 3.10A 1 page 94.2KB
Regulatory Filings
2019-07-08 English
Appendix 3B - Options Exercised 11 pages 369.5KB
Capital/Financing Update
2019-07-07 English
NSB - Breakthrough results from Spinal Cord Injury Model 3 pages 346.7KB
Regulatory Filings
2019-07-01 English
Trading Halt 2 pages 195.9KB
Regulatory Filings
2019-06-30 English
Investor Presentation 21 pages 2.7MB
Investor Presentation
2019-06-11 English
R&D Update 3 pages 316.7KB
Investor Presentation
2019-05-15 English
Appendix 4C - quarterly 5 pages 161.2KB
Interim / Quarterly Report Q3 2019
2019-04-28 English
Investor Presentation 21 pages 9.2MB
Investor Presentation
2019-03-18 English
Shareholder update 1 page 187.6KB
Capital/Financing Update
2019-03-04 English
Entitlement Issue - Shortfall placement 1 page 117.
Capital/Financing Update
2019-02-27 English
Appendix 3B - shortfall allocation 11 pages 366.8KB
Capital/Financing Update
2019-02-27 English
Appendix 4D & Half-Year Financial Statements 16 pages 1.2MB
Interim / Quarterly Report H1 2019
2019-02-24 English
Investor Newsletter 3 pages 680.8KB
Investor Presentation
2019-02-03 English
Appendix 4C - quarterly 5 pages 161.4KB
Interim / Quarterly Report Q2 2018
2019-01-28 English
Appendix 3B - Escrow Release 14 pages 455.9KB
Capital/Financing Update
2019-01-21 English
Notice under ASX Listing Rule 3.10A 1 page 94.6KB
Regulatory Filings
2019-01-08 English